Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
33.40
-0.50 (-1.47%)
May 14, 2026, 4:00 PM EDT

SHA:688139 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
973.45843.83901.231,269951.78774.39
Trading Asset Securities
505.41447.59877.25651.142,0242,130
Cash & Short-Term Investments
1,4791,2911,7781,9202,9752,904
Cash Growth
-14.32%-27.39%-7.39%-35.46%2.45%28.69%
Accounts Receivable
538.91445.28352.76208.35192.17136.29
Other Receivables
8.028.058.567.473.9932
Receivables
546.93453.33361.32215.82196.16168.29
Inventory
337.11345.47334.74248.02270.55345.75
Prepaid Expenses
--0.142.561.210.41
Other Current Assets
378.49568.62177.77149.2145.1938.23
Total Current Assets
2,7412,6592,6522,5363,4893,457
Property, Plant & Equipment
938.84923.01915.18862.22802.08464.13
Long-Term Investments
258.97981.39972.711,030371.85358.34
Goodwill
757.85758.24757.87642.68451.3323.45
Other Intangible Assets
349.9360.5402.3367.73312.35241.62
Long-Term Deferred Tax Assets
94.0289.6766.0151.6730.5235.43
Long-Term Deferred Charges
5.085.66.725.695.460.5
Other Long-Term Assets
709.6514.2514.2429.1826.9119.53
Total Assets
5,8565,7925,7875,5265,4894,900
Accounts Payable
460429.38427.6390.98485.06431.57
Accrued Expenses
63.37242.19228.65235.15245.6196.05
Short-Term Debt
1010.0110.016.0110.01-
Current Portion of Long-Term Debt
80.4910----
Current Portion of Leases
-5.015.763.425.481.65
Current Income Taxes Payable
24.4923.6635.2135.828.6848.01
Current Unearned Revenue
122.88170.92151.98111.81232.84362.05
Other Current Liabilities
307.25194.33163.2158.51176.81104.17
Total Current Liabilities
1,0681,0851,022941.661,1841,144
Long-Term Leases
4.644.547.438.6910.674.32
Long-Term Unearned Revenue
29.9526.0823.1728.6232.8832.18
Long-Term Deferred Tax Liabilities
44.2545.8952.5146.9943.5925.9
Other Long-Term Liabilities
6.316.3163.8159.7569.0355.18
Total Liabilities
1,1541,1681,1691,0861,3411,261
Common Stock
316.49317.95317.95317.95317.95317.07
Additional Paid-In Capital
1,8781,9761,9771,9871,9951,913
Retained Earnings
2,4022,3232,2192,0151,7511,309
Treasury Stock
-150.04-248.68-140.2-99.74-98.07-
Comprehensive Income & Other
7.457.46-2.6910.3753.8984.34
Total Common Equity
4,4544,3764,3724,2314,0213,623
Minority Interest
248.03247.5246.59209.25127.7115.95
Shareholders' Equity
4,7024,6234,6184,4404,1483,639
Total Liabilities & Equity
5,8565,7925,7875,5265,4894,900
Total Debt
95.1329.5523.218.1126.155.97
Net Cash (Debt)
1,3841,2621,7551,9022,9492,898
Net Cash Growth
-18.55%-28.11%-7.73%-35.50%1.76%29.86%
Net Cash Per Share
4.414.035.556.009.289.12
Filing Date Shares Outstanding
317.84311.71314.48315.68316.49317.07
Total Common Shares Outstanding
317.84311.75314.48316.47316.49317.07
Working Capital
1,6731,5731,6301,5942,3042,313
Book Value Per Share
14.0114.0413.9013.3712.7011.43
Tangible Book Value
3,3463,2573,2113,2203,2573,058
Tangible Book Value Per Share
10.5310.4510.2110.1810.299.64
Buildings
-785.74696.63649.88257.73243.72
Machinery
-359.68333.52284.75240.79151.04
Construction In Progress
-54.9795.0370.33389.34130.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.